Roivant Sciences Ltd (ROIV)

Jun 09, 2026

Transcript : Roivant Sciences Ltd. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11 - marketscreener.com

Jun 09, 2026

Jun 09, 2026

Guggenheim Remains Bullish on Roivant Sciences Ltd. (ROIV) - Insider Monkey

Jun 09, 2026

Jun 09, 2026

ROIV: Brepocitinib leads a robust pipeline targeting rare diseases, with strong data and launch plans - TradingView

Jun 09, 2026

Jun 09, 2026

ROIV: Late-stage pipeline advances in rare diseases and immunology, with strong financial flexibility - TradingView

Jun 09, 2026

Jun 08, 2026

Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts - MSN

Jun 08, 2026

Jun 08, 2026

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 36.60% Potential Upside - DirectorsTalk Interviews

Jun 08, 2026

Jun 07, 2026

10 Best Healthcare Stocks to Buy with Highest Upside Potential - Insider Monkey

Jun 07, 2026

Jun 06, 2026

Roivant Sciences’ $2.25 Billion Moderna Settlement: Can Pipeline Momentum Follow? - Smartkarma

Jun 06, 2026

Jun 06, 2026

Roivant gains after mid-stage trial data for Immunovant’s main asset - MSN

Jun 06, 2026

Jun 06, 2026

Precision Trading with Roivant Sciences Ltd. (ROIV) Risk Zones - Stock Traders Daily

Jun 06, 2026

Jun 03, 2026

ROIV: Late-stage pipeline advances and imminent DM launch set up multiple catalysts for the year - TradingView

Jun 03, 2026

Jun 02, 2026

ROIV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 02, 2026

Jun 01, 2026

Did Roivant’s (ROIV) Profitable Quarter and $982 Million Shelf Filing Just Reframe Its Capital Strategy? - simplywall.st

Jun 01, 2026

Jun 01, 2026

Roivant Sciences Ltd. (ROIV) Stock Report: Analyzing The 30.18% Potential Upside - DirectorsTalk Interviews

Jun 01, 2026

Jun 01, 2026

Roivant shares climb on earnings beat despite revenue shortfall (ROIV) - MSN

Jun 01, 2026

May 29, 2026

Roivant Sciences (ROIV) Valuation After Strong IMVT-1402 Data And Late Stage Pipeline Momentum - simplywall.st

May 29, 2026

May 28, 2026

Roivant Sciences Ltd.Common Shares (NQ: ROIV - FinancialContent

May 28, 2026

May 26, 2026

J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $40 - Moomoo

May 26, 2026

May 26, 2026

ROIV Maintained by Guggenheim -- Price Target Raised to $36.00 - GuruFocus

May 26, 2026

May 26, 2026

Roivant Sciences Insider Sold Shares Worth $6,054,000, According to a Recent SEC Filing - Moomoo

May 26, 2026

May 26, 2026

Technical Reactions to ROIV Trends in Macro Strategies - Stock Traders Daily

May 26, 2026

May 26, 2026

Assessing Roivant Sciences (ROIV) Valuation After Strong Recent Share Price Momentum - Yahoo Finance

May 26, 2026

May 25, 2026

Roivant Shelf Plan Raises Questions On Dilution And Pipeline Funding - simplywall.st

May 25, 2026

May 25, 2026

TD Cowen Raises its Price Target on Roivant Sciences (ROIV) - Insider Monkey

May 25, 2026

May 25, 2026

Litigation Windfall Driving Roivant Sciences’ Profit Swing Might Change The Case For Investing In Roivant Sciences (ROIV) - Yahoo Finance

May 25, 2026

May 25, 2026

Today's Analyst Rating | Roivant Sciences Price Target Raised to $31.5 by BofA Securities, UBS Downgrades Millicom International Cellular to Hold - Moomoo

May 25, 2026

May 25, 2026

Roivant Sciences Ltd. (ROIV) - DirectorsTalk Interviews

May 25, 2026

May 23, 2026

Should Roivant’s One‑Off Driven Profitability Shift Require Action From Roivant Sciences (ROIV) Investors? - Sahm

May 23, 2026

May 22, 2026

Roivant Sciences (ROIV) Slips Nearly 3% as Shares Test Key Support ZoneDealer Delta - thelegaladvocate.com

May 22, 2026

May 22, 2026

[Form 4] Roivant Sciences Ltd. Insider Trading Activity - Stock Titan

May 22, 2026

May 22, 2026

A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $34 to $42 - Moomoo

May 22, 2026

May 22, 2026

ROIV Stock Price Prediction 2025-2026 | Roivant Sciences Ltd Forecast - 24/7 Wall St.

May 22, 2026

May 22, 2026

TD Cowen raises Roivant Sciences stock price target to $41 on trial data - Investing.com Australia

May 22, 2026

May 21, 2026

H.C. Wainwright reiterates Roivant Sciences stock rating on IMVT-1402 data By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

ROIV Maintained by Citigroup -- Price Target Raised to $42.00 - GuruFocus

May 21, 2026

May 21, 2026

MSN Money - MSN

May 21, 2026

May 21, 2026

Roivant Sciences Is Maintained at Buy by Citigroup - Moomoo

May 21, 2026

May 21, 2026

ROIV Reiterates by HC Wainwright & Co. -- Price Target Maintained at $34 - GuruFocus

May 21, 2026

May 21, 2026

Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy (NASDAQ:ROIV) - Seeking Alpha

May 21, 2026

May 21, 2026

Piper Sandler reiterates Roivant Sciences stock rating on trial progress By Investing.com - Investing.com Australia

May 21, 2026

May 21, 2026

Leerink raises Roivant Sciences stock price target on drug data By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2025 Earnings Call Transcript - Insider Monkey

May 21, 2026

May 21, 2026

Roivant Sciences Ltd. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ROIV) 2026-05-21 - Seeking Alpha

May 21, 2026